We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The Breast Cancer Now Toby Robins Research Centre at the ICR receives funding from the charity Breast Cancer Now, and was opened in 1999 by Breast Cancer Now's Patron, HRH The Prince of Wales. The ...

Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to ...

Professor Trevor Graham's group harnesses artificial intelligence and the principles of evolution with the aim of improving cancer prevention, diagnosis and treatment. Trevor Graham is Professor of ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite you to join us to hear from leading ...

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

The Division of Breast Cancer Research, which incorporates the Breast Cancer Now Research Centre, contains more than 100 scientists and clinicians working in more than 20 different groups. The ...

The Division of Radiotherapy and Imaging is investigating new imaging methods to diagnose cancer, and ways in which advances in technology and molecular biology can improve radiation treatment. It is ...

Our multidisciplinary centres of excellence and strategic collaborations bring a critical mass of leading researchers together from across the ICR, The Royal Marsden and partner institutions to tackle ...

A new study has shown that non-cancerous cells positioned close to tumours can affect how cancer responds to treatment.

The annual leave entitlement is 28 days upon entry, rising to 29 days after 2 complete years of service, then to 30 days after 5 complete years of service. In addition, employees have an entitlement ...